Sean P. Nolan

Sean P. Nolan is a former chief executive of AveXis, the company behind the development of Zolgensma, a gene therapy for spinal muscular atrophy (SMA). He played a pivotal role in taking the company public and navigating the commercialization of the drug amidst rising scrutiny over drug pricing.